Triple

T18923912
Position Surface form Disambiguated ID Type / Status
Subject WHO Collaborating Centre for Drug Statistics Methodology E462928 entity
Predicate methodologyName P133810 FINISHED
Object ATC/DDD methodology NE NERFINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: ATC/DDD methodology | Statement: [WHO Collaborating Centre for Drug Statistics Methodology, methodologyName, ATC/DDD methodology]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: ATC/DDD methodology
Context triple: [WHO Collaborating Centre for Drug Statistics Methodology, methodologyName, ATC/DDD methodology]
  • A. WHO Collaborating Centre for Drug Statistics Methodology
    The WHO Collaborating Centre for Drug Statistics Methodology is a specialized World Health Organization center responsible for developing and maintaining international standards for drug classification and consumption statistics, including the ATC/DDD system.
  • B. Defined Daily Dose system chosen
    The Defined Daily Dose system is a standardized measure used in pharmacology to quantify and compare drug consumption by assigning an assumed average maintenance dose per day for a drug’s main indication in adults.
  • C. Pharmacovigilance Risk Assessment Committee within the European Medicines Agency
    The Pharmacovigilance Risk Assessment Committee within the European Medicines Agency is an expert body responsible for evaluating and monitoring the safety of medicines across the European Union and providing recommendations on managing and communicating medicine-related risks.
  • D. FDA Risk Evaluation and Mitigation Strategies authority
    The FDA Risk Evaluation and Mitigation Strategies authority is the U.S. Food and Drug Administration’s power to require special safety measures and monitoring programs for certain high-risk prescription drugs to ensure their benefits outweigh their risks.
  • E. World Health Organization Model List of Essential Medicines
    The World Health Organization Model List of Essential Medicines is a periodically updated catalog of the most effective, safe, and cost-efficient medicines deemed essential for meeting the priority health needs of populations worldwide.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
PD Predicate disambiguation gpt-5-mini-2025-08-07
Target predicate: methodologyName
Context triple: [WHO Collaborating Centre for Drug Statistics Methodology, methodologyName, ATC/DDD methodology]
  • A. methodologyType
    Indicates the specific kind or category of method or procedure used in carrying out an activity or study.
  • B. methodologicallyAssociatedWith
    Indicates a relationship where two entities are connected through shared, related, or jointly applied methods, procedures, or methodological approaches.
  • C. methodologicalStyle
    Indicates the characteristic approach, techniques, or procedures used in carrying out a method or research process.
  • D. describesMethodology
    Indicates that one entity explains, specifies, or characterizes the methodology or procedure used by another entity.
  • E. methodologicalStatus
    Indicates the methodological role or classification that one entity assigns to another within a research or analytical framework.
  • F. None of above. chosen

Provenance (4 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d8dcfdbbb881909964fa5a75bd0b48 completed April 10, 2026, 11:20 a.m.
NER Named-entity recognition batch_69e5c9b549448190850d7eed4de7872b completed April 20, 2026, 6:37 a.m.
PD Predicate disambiguation batch_69e4a2e9e6488190ba8df92c8058ed88 completed April 19, 2026, 9:39 a.m.
PDg Predicate description generation batch_69e4ad8e075c8190ad561edc5e520057 completed April 19, 2026, 10:25 a.m.
Created at: April 10, 2026, 11:59 a.m.